首页 > 最新文献

Intensive Care Medicine最新文献

英文 中文
Individualized response to awake prone positioning in COVID-19 patients: need deeper insights. COVID-19患者对清醒俯卧位的个体化反应:需要更深入的了解。
IF 27.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-11-20 DOI: 10.1007/s00134-024-07729-5
Ling Liu, Qin Sun, Yi Yang, Haibo Qiu, Arthur S Slutsky
{"title":"Individualized response to awake prone positioning in COVID-19 patients: need deeper insights.","authors":"Ling Liu, Qin Sun, Yi Yang, Haibo Qiu, Arthur S Slutsky","doi":"10.1007/s00134-024-07729-5","DOIUrl":"https://doi.org/10.1007/s00134-024-07729-5","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":""},"PeriodicalIF":27.1,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence interpretation of chest radiographs in intensive care. Ready for prime time? 重症监护中胸片的人工智能解读。准备好进入黄金时间了吗?
IF 38.9 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-11-20 DOI: 10.1007/s00134-024-07725-9
Leo Joskowicz, Michael Beil, Sigal Sviri
{"title":"Artificial Intelligence interpretation of chest radiographs in intensive care. Ready for prime time?","authors":"Leo Joskowicz, Michael Beil, Sigal Sviri","doi":"10.1007/s00134-024-07725-9","DOIUrl":"https://doi.org/10.1007/s00134-024-07725-9","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"36 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142673287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[18F]FDG PET/CT to diagnose inflammation in critically ill immunocompromised patients. 用[18F]FDG PET/CT 诊断免疫力低下的重症患者的炎症。
IF 27.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-11-20 DOI: 10.1007/s00134-024-07723-x
B van Leer, C P van Stee, A W J M Glaudemans, G J Westland, J Pillay
{"title":"[<sup>18</sup>F]FDG PET/CT to diagnose inflammation in critically ill immunocompromised patients.","authors":"B van Leer, C P van Stee, A W J M Glaudemans, G J Westland, J Pillay","doi":"10.1007/s00134-024-07723-x","DOIUrl":"https://doi.org/10.1007/s00134-024-07723-x","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":""},"PeriodicalIF":27.1,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Position paper on the physiology and nomenclature of dual circulation during venoarterial ECMO in adults. 关于成人静脉动脉 ECMO 期间双循环生理学和术语的立场文件。
IF 27.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-11-18 DOI: 10.1007/s00134-024-07645-8
Jenelle Badulak, Darryl Abrams, Andrew M Luks, Bishoy Zakhary, Steven A Conrad, Robert Bartlett, Graeme MacLaren, Leen Vercaemst, Roberto Lorusso, Lars Mikael Broman, Cara Agerstrand, Susanna Price, Alain Combes, Giles Peek, Eddy Fan, Kiran Shekar, John Fraser, Daniel Brodie

When native blood flow through the aorta from the adult heart and lungs meets retrograde blood flow from an artificial heart and lung during venoarterial extracorporeal membrane oxygenation (VA-ECMO), the result is the creation of two separate circulations on either side of the blood flow mixing point. This phenomenon is known as dual circulation and is characterized by different content of oxygen and carbon dioxide between the circulations. There is currently a lack of clarity surrounding the nomenclature to describe this physiologic phenomenon in VA-ECMO and thus we endeavor to name and define these terms to facilitate clear communication and proper clinical management of these patients.

在静脉-动脉体外膜氧合(VA-ECMO)过程中,当来自成人心肺的主动脉原生血流与来自人工心肺的逆行血流相遇时,就会在血流混合点两侧形成两个独立的循环。这种现象被称为双循环,其特点是循环之间的氧气和二氧化碳含量不同。目前,描述 VA-ECMO 这种生理现象的术语还不够清晰,因此我们努力命名和定义这些术语,以促进清晰的沟通和对这些患者的正确临床管理。
{"title":"Position paper on the physiology and nomenclature of dual circulation during venoarterial ECMO in adults.","authors":"Jenelle Badulak, Darryl Abrams, Andrew M Luks, Bishoy Zakhary, Steven A Conrad, Robert Bartlett, Graeme MacLaren, Leen Vercaemst, Roberto Lorusso, Lars Mikael Broman, Cara Agerstrand, Susanna Price, Alain Combes, Giles Peek, Eddy Fan, Kiran Shekar, John Fraser, Daniel Brodie","doi":"10.1007/s00134-024-07645-8","DOIUrl":"10.1007/s00134-024-07645-8","url":null,"abstract":"<p><p>When native blood flow through the aorta from the adult heart and lungs meets retrograde blood flow from an artificial heart and lung during venoarterial extracorporeal membrane oxygenation (VA-ECMO), the result is the creation of two separate circulations on either side of the blood flow mixing point. This phenomenon is known as dual circulation and is characterized by different content of oxygen and carbon dioxide between the circulations. There is currently a lack of clarity surrounding the nomenclature to describe this physiologic phenomenon in VA-ECMO and thus we endeavor to name and define these terms to facilitate clear communication and proper clinical management of these patients.</p>","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":""},"PeriodicalIF":27.1,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early physiologic changes after awake prone positioning predict clinical outcomes in patients with acute hypoxemic respiratory failure. 清醒俯卧位后的早期生理变化可预测急性低氧血症呼吸衰竭患者的临床预后。
IF 27.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-11-14 DOI: 10.1007/s00134-024-07690-3
Matias Olmos, Mariano Esperatti, Nora Fuentes, Anabel Miranda Tirado, María Eugenia Gonzalez, Hiromi Kakisu, Juan Suarez, Manuel Tisminetzky, Veronica Barbaresi, Ignacio Santomil, Alejandro Bruhn Cruz, Domenico Luca Grieco, Bruno L Ferreyro

Purpose: The optimal physiologic parameters to monitor after a session of awake prone positioning in patients with acute respiratory failure are not well understood. This study aimed to identify which early physiologic changes after the first session of awake prone positioning are linked to the need for invasive mechanical ventilation or death in patients with acute respiratory failure.

Methods: We performed a secondary analysis of a prospective cohort study of adult patients with acute respiratory failure related to coronavirus disease 2019 (COVID-19) treated with awake prone positioning. We assessed the association between relative changes in physiological variables (oxygenation, respiratory rate, pCO2 and respiratory rate-oxygenation [ROX] index) within the first 6 h of the first awake prone positioning session with treatment failure, defined as endotracheal intubation and/or death within 7 days.

Results: 244 patients [70 female (29%), mean age 60 (standard deviation [SD] 13) years] were included. Seventy-one (29%) patients experienced awake prone positioning failure. ROX index was the main physiologic predictor. Patients with treatment failure had lower mean [SD] ROX index at baseline [5 (1.4) versus 6.6 (2.2), p < 0.0001] and within 6 h of prone positioning [5.6 (1.7) versus 8.7 (2.8), p < 0.0001]. After adjusting for baseline characteristics and severity, a relative increase of the ROX index compared to baseline was associated with lower odds of failure [odds ratio (OR) 0.37; 95% confidence interval (CI) 0.25-0.54 every 25% increase].

Conclusion: Relative changes in the ROX index within 6 h of the first awake prone positioning session along with other known predictive factors are associated with intubation and mortality at day 7.

目的:对急性呼吸衰竭患者进行清醒俯卧位治疗后监测的最佳生理参数尚不十分清楚。本研究旨在确定急性呼吸衰竭患者在首次清醒俯卧位后的早期生理变化与有创机械通气需求或死亡的关系:我们对一项前瞻性队列研究进行了二次分析,研究对象是接受清醒俯卧位治疗的2019年冠状病毒病(COVID-19)急性呼吸衰竭成年患者。我们评估了首次清醒俯卧位治疗后6小时内生理变量(氧饱和度、呼吸频率、pCO2和呼吸频率-氧饱和度[ROX]指数)的相对变化与治疗失败(定义为7天内气管插管和/或死亡)之间的关联。结果:共纳入244名患者[70名女性(29%),平均年龄60(标准差[SD]13)岁]。71名患者(29%)经历了清醒俯卧位失败。ROX指数是主要的生理预测指标。治疗失败的患者基线时的平均 ROX 指数[标准差]较低[5 (1.4) 对 6.6 (2.2), p 结论:首次清醒俯卧位治疗后 6 小时内 ROX 指数的相对变化以及其他已知的预测因素与插管和第 7 天的死亡率有关。
{"title":"Early physiologic changes after awake prone positioning predict clinical outcomes in patients with acute hypoxemic respiratory failure.","authors":"Matias Olmos, Mariano Esperatti, Nora Fuentes, Anabel Miranda Tirado, María Eugenia Gonzalez, Hiromi Kakisu, Juan Suarez, Manuel Tisminetzky, Veronica Barbaresi, Ignacio Santomil, Alejandro Bruhn Cruz, Domenico Luca Grieco, Bruno L Ferreyro","doi":"10.1007/s00134-024-07690-3","DOIUrl":"10.1007/s00134-024-07690-3","url":null,"abstract":"<p><strong>Purpose: </strong>The optimal physiologic parameters to monitor after a session of awake prone positioning in patients with acute respiratory failure are not well understood. This study aimed to identify which early physiologic changes after the first session of awake prone positioning are linked to the need for invasive mechanical ventilation or death in patients with acute respiratory failure.</p><p><strong>Methods: </strong>We performed a secondary analysis of a prospective cohort study of adult patients with acute respiratory failure related to coronavirus disease 2019 (COVID-19) treated with awake prone positioning. We assessed the association between relative changes in physiological variables (oxygenation, respiratory rate, pCO<sub>2</sub> and respiratory rate-oxygenation [ROX] index) within the first 6 h of the first awake prone positioning session with treatment failure, defined as endotracheal intubation and/or death within 7 days.</p><p><strong>Results: </strong>244 patients [70 female (29%), mean age 60 (standard deviation [SD] 13) years] were included. Seventy-one (29%) patients experienced awake prone positioning failure. ROX index was the main physiologic predictor. Patients with treatment failure had lower mean [SD] ROX index at baseline [5 (1.4) versus 6.6 (2.2), p < 0.0001] and within 6 h of prone positioning [5.6 (1.7) versus 8.7 (2.8), p < 0.0001]. After adjusting for baseline characteristics and severity, a relative increase of the ROX index compared to baseline was associated with lower odds of failure [odds ratio (OR) 0.37; 95% confidence interval (CI) 0.25-0.54 every 25% increase].</p><p><strong>Conclusion: </strong>Relative changes in the ROX index within 6 h of the first awake prone positioning session along with other known predictive factors are associated with intubation and mortality at day 7.</p>","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":""},"PeriodicalIF":27.1,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fludrocortisone with hydrocortisone in sepsis: new evidence in an ongoing debate. 败血症中的氟氢可的松与氢化可的松:持续争论中的新证据。
IF 27.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-11-12 DOI: 10.1007/s00134-024-07699-8
Otavio Ranzani, Djillali Annane, Mervyn Singer
{"title":"Fludrocortisone with hydrocortisone in sepsis: new evidence in an ongoing debate.","authors":"Otavio Ranzani, Djillali Annane, Mervyn Singer","doi":"10.1007/s00134-024-07699-8","DOIUrl":"https://doi.org/10.1007/s00134-024-07699-8","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":""},"PeriodicalIF":27.1,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chlorhexidine-alcohol compared with povidone-iodine-alcohol skin antisepsis protocols in major cardiac surgery: a randomized clinical trial 心脏大手术中氯己定-酒精与聚维酮-碘-酒精皮肤防腐方案的比较:随机临床试验
IF 38.9 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-11-12 DOI: 10.1007/s00134-024-07693-0
Matthieu Boisson, Géraldine Allain, Jean-Christian Roussel, Nicolas d’Ostrevy, Silvia Burbassi, Pierre Demondion, Paul-Michel Mertes, François Labaste, Thomas Kerforne, Bertrand Rozec, Vedat Eljezi, Konstantinos Zannis, Pascal Leprince, Walid Oulehri, Vincent Minville, Sabrina Seguin, Ambre Loiodice, Stéphane Ruckly, Jean-Christophe Lucet, Jean-François Timsit, Olivier Mimoz

Purpose

Whether skin disinfection of the surgical site using chlorhexidine-alcohol is superior to povidone-iodine-alcohol in reducing reoperation and surgical site infection rates after major cardiac surgery remains unclear.

Methods

CLEAN 2 was a multicenter, open-label, randomized, two-arm, assessor-blind, superiority trial conducted in eight French hospitals. We randomly assigned adult patients undergoing major heart or aortic surgery via sternotomy, with or without saphenous vein or radial artery harvesting, to have all surgical sites disinfected with either 2% chlorhexidine-alcohol or 5% povidone-iodine-alcohol. The primary outcome was any resternotomy by day 90 or any reoperation at the peripheral surgical site by day 30.

Results

Of 3242 patients (1621 in the chlorhexidine-alcohol group [median age, 69 years; 1276 (78.7%) men] and 1621 in the povidone-iodine-alcohol group [median age, 69 years; 1247 (76.9%) men], the percentage required reoperation within 90 days was similar (7.7% [125/1621] in the chlorhexidine-alcohol group vs 7.5% [121/1621] in the povidone-iodine-alcohol group; risk difference, 0.25 [95% confidence interval (CI), − 1.58–2.07], P = 0.79). The incidence of surgical site infections at the sternum or peripheral sites was similar (4% [65/1621] in the chlorhexidine-alcohol group vs 3.3% [53/1621] in the povidone-iodine-alcohol group; risk difference, 0.74 [95% CI − 0.55–2.03], P = 0.26). Length of hospital stay, intensive care unit or hospital readmission, mortality and surgical site adverse events were similar between the two groups.

Conclusion

Among patients requiring sternotomy for major heart or aortic surgery, skin disinfection at the surgical site using chlorhexidine-alcohol was not superior to povidone-iodine-alcohol for reducing reoperation and surgical site infection rates.

目的 在降低心脏大手术后的再次手术率和手术部位感染率方面,使用氯己定酒精对手术部位进行皮肤消毒是否优于聚维酮碘酒精,目前仍不清楚。我们随机分配了通过胸骨切开术接受心脏或主动脉大手术的成年患者,无论是否采集了隐静脉或桡动脉,所有手术部位均使用 2% 氯己定酒精或 5% 聚维酮碘酒精进行消毒。结果在 3242 名患者中(洗必泰酒精组 1621 人[中位年龄 69 岁;男性 1276 人(78.7%)],聚维酮碘酒组 1621 人[中位年龄 69 岁;男性 1247 人(76.9%)]),使用 2% 洗必泰酒精或 5% 聚维酮碘酒消毒所有手术部位的患者所占比例分别为:1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%、1%。90天内需要再次手术的比例相似(洗必泰酒精组 7.7% [125/1621] vs 聚维酮碘酒组 7.5% [121/1621];风险差异,0.25 [95% 置信区间 (CI),- 1.58-2.07],P = 0.79)。胸骨或外周部位的手术部位感染发生率相似(洗必泰酒精组为 4% [65/1621] ,聚维酮碘酒精组为 3.3% [53/1621];风险差异为 0.74 [95% CI - 0.55-2.03],P = 0.26)。结论在需要进行胸骨切开术的心脏或主动脉大手术患者中,使用洗必泰-酒精进行手术部位皮肤消毒在降低再次手术率和手术部位感染率方面并不优于聚维酮-碘-酒精。
{"title":"Chlorhexidine-alcohol compared with povidone-iodine-alcohol skin antisepsis protocols in major cardiac surgery: a randomized clinical trial","authors":"Matthieu Boisson, Géraldine Allain, Jean-Christian Roussel, Nicolas d’Ostrevy, Silvia Burbassi, Pierre Demondion, Paul-Michel Mertes, François Labaste, Thomas Kerforne, Bertrand Rozec, Vedat Eljezi, Konstantinos Zannis, Pascal Leprince, Walid Oulehri, Vincent Minville, Sabrina Seguin, Ambre Loiodice, Stéphane Ruckly, Jean-Christophe Lucet, Jean-François Timsit, Olivier Mimoz","doi":"10.1007/s00134-024-07693-0","DOIUrl":"https://doi.org/10.1007/s00134-024-07693-0","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Whether skin disinfection of the surgical site using chlorhexidine-alcohol is superior to povidone-iodine-alcohol in reducing reoperation and surgical site infection rates after major cardiac surgery remains unclear.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>CLEAN 2 was a multicenter, open-label, randomized, two-arm, assessor-blind, superiority trial conducted in eight French hospitals. We randomly assigned adult patients undergoing major heart or aortic surgery via sternotomy, with or without saphenous vein or radial artery harvesting, to have all surgical sites disinfected with either 2% chlorhexidine-alcohol or 5% povidone-iodine-alcohol. The primary outcome was any resternotomy by day 90 or any reoperation at the peripheral surgical site by day 30.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Of 3242 patients (1621 in the chlorhexidine-alcohol group [median age, 69 years; 1276 (78.7%) men] and 1621 in the povidone-iodine-alcohol group [median age, 69 years; 1247 (76.9%) men], the percentage required reoperation within 90 days was similar (7.7% [125/1621] in the chlorhexidine-alcohol group vs 7.5% [121/1621] in the povidone-iodine-alcohol group; risk difference, 0.25 [95% confidence interval (CI), − 1.58–2.07], <i>P</i> = 0.79). The incidence of surgical site infections at the sternum or peripheral sites was similar (4% [65/1621] in the chlorhexidine-alcohol group vs 3.3% [53/1621] in the povidone-iodine-alcohol group; risk difference, 0.74 [95% CI − 0.55–2.03], <i>P</i> = 0.26). Length of hospital stay, intensive care unit or hospital readmission, mortality and surgical site adverse events were similar between the two groups.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Among patients requiring sternotomy for major heart or aortic surgery, skin disinfection at the surgical site using chlorhexidine-alcohol was not superior to povidone-iodine-alcohol for reducing reoperation and surgical site infection rates.</p>","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"2 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142599745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beta-blockers as antiarrhythmics in septic shock: a light at the end of the tunnel? β-受体阻滞剂作为脓毒性休克的抗心律失常药物:隧道尽头的曙光?
IF 38.9 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-11-12 DOI: 10.1007/s00134-024-07713-z
Martin Balik, G. Tavazzi, M. Slama
{"title":"Beta-blockers as antiarrhythmics in septic shock: a light at the end of the tunnel?","authors":"Martin Balik, G. Tavazzi, M. Slama","doi":"10.1007/s00134-024-07713-z","DOIUrl":"https://doi.org/10.1007/s00134-024-07713-z","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"164 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142599743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sepsis: key insights, future directions, and immediate goals. A review and expert opinion 败血症:主要见解、未来方向和近期目标。综述和专家意见
IF 38.9 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-11-12 DOI: 10.1007/s00134-024-07694-z
Ignacio Martin-Loeches, Mervyn Singer, Marc Leone

This review explores the current landscape and evolving understanding of sepsis, highlighting both challenges and future directions. Sepsis remains a major global health burden, with diverse clinical presentations complicating timely diagnosis and management. Existing definitions, including the Sepsis-3 criteria, emphasize the importance of organ dysfunction, yet early sepsis detection remains limited by available tools. The Sequential Organ Failure Assessment (SOFA) score, though widely used, may not fully capture early stages of infection or account for complex presentations like noncatecholamine-resistant shock. Additionally, the review underscores the pressing need for standardized terminology across sepsis and shock characterization to ensure consistency in diagnosis and treatment strategies. Accessible, resource-adapted solutions are particularly crucial in low- and middle-income countries where sepsis-related mortality rates are higher due to limited resources. Future research should focus on developing and validating integrated, multi-parameter tools that combine clinical, biochemical, and microbiological data to improve sepsis outcomes globally. Advancing sepsis care will require both technological innovation and collaborative, globally consistent guidelines to bridge disparities in healthcare delivery.

这篇综述探讨了败血症的现状和不断发展的认识,强调了挑战和未来的方向。败血症仍然是全球主要的健康负担,其多样化的临床表现使及时诊断和管理变得复杂。包括败血症-3 标准在内的现有定义强调了器官功能障碍的重要性,但早期败血症检测仍受到现有工具的限制。器官功能衰竭顺序评估(SOFA)评分虽然被广泛使用,但可能无法完全捕捉到感染的早期阶段,也无法解释非儿茶酚胺抵抗性休克等复杂表现。此外,综述还强调了脓毒症和休克特征描述迫切需要标准化术语,以确保诊断和治疗策略的一致性。在中低收入国家,由于资源有限,与脓毒症相关的死亡率较高,因此可获得的、与资源相适应的解决方案尤为重要。未来的研究应侧重于开发和验证结合临床、生化和微生物学数据的多参数综合工具,以在全球范围内改善败血症的治疗效果。推进脓毒症治疗需要技术创新和全球一致的合作指南,以消除医疗服务中的差异。
{"title":"Sepsis: key insights, future directions, and immediate goals. A review and expert opinion","authors":"Ignacio Martin-Loeches, Mervyn Singer, Marc Leone","doi":"10.1007/s00134-024-07694-z","DOIUrl":"https://doi.org/10.1007/s00134-024-07694-z","url":null,"abstract":"<p>This review explores the current landscape and evolving understanding of sepsis, highlighting both challenges and future directions. Sepsis remains a major global health burden, with diverse clinical presentations complicating timely diagnosis and management. Existing definitions, including the Sepsis-3 criteria, emphasize the importance of organ dysfunction, yet early sepsis detection remains limited by available tools. The Sequential Organ Failure Assessment (SOFA) score, though widely used, may not fully capture early stages of infection or account for complex presentations like noncatecholamine-resistant shock. Additionally, the review underscores the pressing need for standardized terminology across sepsis and shock characterization to ensure consistency in diagnosis and treatment strategies. Accessible, resource-adapted solutions are particularly crucial in low- and middle-income countries where sepsis-related mortality rates are higher due to limited resources. Future research should focus on developing and validating integrated, multi-parameter tools that combine clinical, biochemical, and microbiological data to improve sepsis outcomes globally. Advancing sepsis care will require both technological innovation and collaborative, globally consistent guidelines to bridge disparities in healthcare delivery.</p>","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"147 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142599807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Air pollutant exposure and mortality risk of critically ill patients 空气污染物暴露与危重病人的死亡风险
IF 38.9 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-11-12 DOI: 10.1007/s00134-024-07700-4
Chen Li, Huzhi Yao, Zhanpeng Wang, Zhicheng Fang, Peng Jia, Jingjun Lv
{"title":"Air pollutant exposure and mortality risk of critically ill patients","authors":"Chen Li, Huzhi Yao, Zhanpeng Wang, Zhicheng Fang, Peng Jia, Jingjun Lv","doi":"10.1007/s00134-024-07700-4","DOIUrl":"https://doi.org/10.1007/s00134-024-07700-4","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"71 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142599742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Intensive Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1